What You Should Know:
– Evolent Health, Inc., a company focused on improving health outcomes for people with complex conditions, has reached a definitive agreement to sell its value-based primary care business, Evolent Care Partners (ECP), to Privia Health Group, Inc..
– ECP is a major participant in the Medicare Shared Savings Program (MSSP), partnering with over 1,000 physicians to serve more than 120,000 members across the nation.
Transaction Details and Financial Strategy
The total value of the transaction is up to $113M, payable in cash. This includes $100M at closing, with the remaining balance due in Fall 2026 based on the final MSSP performance for 2025. Evolent plans to use all net proceeds from the sale to repay borrowings on its senior credit facility. This strategic divestiture is intended to allow Evolent to focus on its core specialty business while accelerating its path to reducing leverage and improving cash flow.
Evolent estimates that ECP is currently generating roughly $10M in adjusted EBITDA.
The company projects that the debt prepayment will result in a reduction in interest expense of approximately $10M. Net of the reduced cash generation from ECP, Evolent expects the transaction to improve its annual cash flow by more than $7M annually.
Evolent also reiterated its financial outlook for the full year 2025, prior to giving effect to this transaction, projecting Revenue between $1.85–$1.88B and Adjusted EBITDA between $140–$165M. For Q3 2025, the company reiterated an outlook for Revenue of between $460M and $480M, and Adjusted EBITDA between $34M and $42M.
